Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Franklin Resources, Inc. (BEN) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

Franklin Resources, Inc.Trade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

Franklin Resources, Inc. vs Zimmer Biomet Holdings Inc — how do they compare? Franklin Resources, Inc. trades at $33.37 (market cap $16.95B), while Zimmer Biomet Holdings Inc trades at $97.27 (market cap $18.55B). The key difference: Franklin Resources, Inc. and Zimmer Biomet Holdings Inc are close in size by market cap, and Franklin Resources, Inc. pays the higher dividend (3.96%). Which is the better fit depends on your goals.

BENZBH
Market Cap
$16.95B$18.55B
Sector
FinancialsHealth
52-Week High
$35.77$107.71
52-Week Low
$21.18$79.58
Enterprise Value
$29.90B$25.61B
Dividend Yield
3.96%0.99%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Franklin Resources, Inc.

Franklin Resources provides investment services for individual and institutional investors. At the end of August 2022, Franklin had $1.388 trillion in managed assets, composed primarily of equity (32%), fixed-income (38%), multi-asset/balanced (10%) funds, alternatives (16%), and money market funds (4%). Distribution tends to be weighted more toward retail investors (49% of AUM) investors, as opposed to institutional (49%) and high-net-worth (2%) clients. Franklin is also one of the more global firms of the U.S.-based asset managers with more than 35% of its AUM invested in global/international strategies and 25% of managed assets sourced from clients domiciled outside the United States.

Read more on BEN

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH